On today's show Andrew and Bill break down the latest deal between the US and China, beginning with details from the White House over the weekend, why the PRC is likely happy with a tactical retreat and the new status quo, and why stability is likely at least through April. From there: Why the PRC was motivated to deal despite its goals of eliminating tariffs and export controls, clarity about American pain points, questions about Congress and what comes next, and the costs of China's strategy for the past month. At the end: Reporting on a doomed push from Nvidia to sell Blackwell chips to China, new subsidies for China's AI leaders, a potential Nexperia resolution, and questions the forthcoming fentanyl cooperation between the US and China.
All content for Sharp China with Bill Bishop is the property of Andrew Sharp and Sinocism’s Bill Bishop and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
On today's show Andrew and Bill break down the latest deal between the US and China, beginning with details from the White House over the weekend, why the PRC is likely happy with a tactical retreat and the new status quo, and why stability is likely at least through April. From there: Why the PRC was motivated to deal despite its goals of eliminating tariffs and export controls, clarity about American pain points, questions about Congress and what comes next, and the costs of China's strategy for the past month. At the end: Reporting on a doomed push from Nvidia to sell Blackwell chips to China, new subsidies for China's AI leaders, a potential Nexperia resolution, and questions the forthcoming fentanyl cooperation between the US and China.
(Preview) Xi on Development and Three-Patting Cadres; PRC Venture Investing; Exit Ban Controversies; H20s and a New Trump Narrative; The Big Tariff
Sharp China with Bill Bishop
10 minutes 38 seconds
3 months ago
(Preview) Xi on Development and Three-Patting Cadres; PRC Venture Investing; Exit Ban Controversies; H20s and a New Trump Narrative; The Big Tariff
On today's show Andrew and Bill begin with comments from Xi Jinping and renewed emphasis on building more rational marketplaces across key sectors in tech and beyond. Topics include: The implication that not every province has to participate in new growth areas, cadres parsing conflicting guidance from Beijing, and efforts to stimulate a healthy investment ecosystem for startups as U.S. venture investment recedes. From there: Thoughts on two high-profile exit-bans on American citizens traveling in China, why the two cases are different, more chatter that the Trump administration is softening on China, counterpoints to that argument, and a bit more news on "The Big Tariff," Yang Hansen.
Sharp China with Bill Bishop
On today's show Andrew and Bill break down the latest deal between the US and China, beginning with details from the White House over the weekend, why the PRC is likely happy with a tactical retreat and the new status quo, and why stability is likely at least through April. From there: Why the PRC was motivated to deal despite its goals of eliminating tariffs and export controls, clarity about American pain points, questions about Congress and what comes next, and the costs of China's strategy for the past month. At the end: Reporting on a doomed push from Nvidia to sell Blackwell chips to China, new subsidies for China's AI leaders, a potential Nexperia resolution, and questions the forthcoming fentanyl cooperation between the US and China.
